Novum Pharma Expands, Upgrades Las Vegas Clinical Facility

Published: Oct 12, 2017

LAS VEGAS, Oct. 12, 2017 /PRNewswire/ -- Novum Pharmaceutical Research Services, a leading U.S. clinical research company, has completed significant upgrades to its Las Vegas, Nevada clinical facility, which it has operated since 2004. Novum has refurbished study clinics, screening areas, and outpatient returns at its 34,000 square foot Pecos McLeod facility, and added a new administrative wing adjacent to the clinic, formerly the Talmer Bank and Trust building.

"Novum's early phase research business has greatly diversified over the last several years in terms of study types and activities, as we evolve to serve a dynamic pharmaceutical industry," said Christopher H. Chamberlain, Novum's President and CEO. "The upgrades to our Las Vegas site align it with the increasingly complex scope of our early phase work, and provide a more comfortable and convenient experience for our study participants," he added.

Since opening in Las Vegas in 2004, Novum has conducted thousands of clinical research studies and paid over $20 million dollars to area residents for participating in clinical trials. Novum, with headquarters in Pittsburgh PA, employs over 100 Las Vegas staff members.

"We modernized our facilities to provide state-of-the-art services to our clients and study volunteers, but it's also a sign of our deep commitment to being a part of the Las Vegas community," said Dr. Darin Brimhall, Vice President of Clinic Operations. Dr. Brimhall is based in Las Vegas.

The Las Vegas clinic expansion follows an expansion of Novum's Houston, TX facility in 2013, and its acquisition of a clinic unit in Fargo, ND the same year.

To participate in a Novum research study, please contact our local Las Vegas Novum recruiting team at 702-435-3902 or register online at

Start your career with Novum PRS Las Vegas by exploring career opportunities ("EOE") at

About Novum Pharmaceutical Research Services

Novum is a U.S. contract research organization ("CRO") that provides Phase I through IV clinical research, data management, statistical and reporting services to the pharmaceutical and related industries.  Founded in 1972, it operates Early Phase research facilities in three U.S. locations.  Novum's Clinical Trial Management group conducts Phase II through IV clinical endpoint studies requiring large patient numbers across numerous therapeutic areas.  Please visit for more corporate information and to register and receive updates on study participant opportunities.


Andrea Atencio

Novum Pharmaceutical Research Services

412-363-3300 x578 


View original content:

SOURCE Novum Pharmaceutical Research Services

Back to news